{"title":"Evaluation of Clinical Management of COVID-19 Patients in China in the Year 2020","authors":"Jie Lin, Ting Zheng, Jiahui Guan, Feiyan Wang","doi":"10.37290/ctnr2641-452x.21:440-447","DOIUrl":null,"url":null,"abstract":"Our research aimed to analyze the application and outcome of several common antiviral drugs and the traditional Chinese medicine formulations for COVID-19 during the early months (January 20, 2020 to December 30, 2020) of the epidemics in China. Patients were clinically classified into mild, common, severe, and critical types based on their clinical symptoms, pulmonary imaging findings, and complications. During the study period, antiviral treatment was administered to 482 patients, with 342 patients receiving a combination of traditional Chinese and Western medicine, accounting for 80.60% and 57.19% of the discharged COVID-19 patients (598 cases), respectively. The main treatment consisted of monotherapy with lopinavir/ ritonavir, arbidol, and chloroquine phosphate, with a need to change the treatment regimen in 29.88% of patients. Three traditional Chinese medicine formulations—Huoxiangzhengqi Liquid, Lianhuaqingwen Jiaonang, and Shufeng Jiedu Jiaonang—were used for COVID-19 treatment and showed good curing effects for patients with mild common clinical classification. Antiviral-related adverse effects were experienced by a total of 142 patients (29.46%). To sum up, antiviral and TCM treatments remain the mainstays of therapy for COVID-19 and show good effects.","PeriodicalId":10976,"journal":{"name":"Current Topics in Nutraceutical Research","volume":"188 1","pages":"0"},"PeriodicalIF":0.4000,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Topics in Nutraceutical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37290/ctnr2641-452x.21:440-447","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Our research aimed to analyze the application and outcome of several common antiviral drugs and the traditional Chinese medicine formulations for COVID-19 during the early months (January 20, 2020 to December 30, 2020) of the epidemics in China. Patients were clinically classified into mild, common, severe, and critical types based on their clinical symptoms, pulmonary imaging findings, and complications. During the study period, antiviral treatment was administered to 482 patients, with 342 patients receiving a combination of traditional Chinese and Western medicine, accounting for 80.60% and 57.19% of the discharged COVID-19 patients (598 cases), respectively. The main treatment consisted of monotherapy with lopinavir/ ritonavir, arbidol, and chloroquine phosphate, with a need to change the treatment regimen in 29.88% of patients. Three traditional Chinese medicine formulations—Huoxiangzhengqi Liquid, Lianhuaqingwen Jiaonang, and Shufeng Jiedu Jiaonang—were used for COVID-19 treatment and showed good curing effects for patients with mild common clinical classification. Antiviral-related adverse effects were experienced by a total of 142 patients (29.46%). To sum up, antiviral and TCM treatments remain the mainstays of therapy for COVID-19 and show good effects.
期刊介绍：
Current Topics in Nutraceutical Research is an international, interdisciplinary broad-based peer reviewed scientific journal for critical evaluation of research on chemistry, biology and therapeutic applications of nutraceuticals and functional foods. The major goal of this journal is to provide peer reviewed unbiased scientific data to the decision makers in the nutraceutical and food industry to help make informed choices about development of new products.
To this end, the journal will publish two types of review articles. First, a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, a critical evaluation of current human experimental data to help market and deliver the product for medically proven use. This journal will also serve as a forum for nutritionists, internists, neurologists, psychiatrists, and all those interested in preventive medicine.
The common denominator of all of the topic to be covered by the journal must include nutraceuticals and/functional food. The following is an example of some specific areas that may be of interest to the journal. i) Role of vitamins, minerals, antioxidants and phytonutrients on cardiovascular health, cancer, diabetes, ocular health, mental health, men’s health, women’s health, infant nutrition, ii) Role of herbals on human health, iii) Dietary supplements and sleep, iv) Components of diet that may have beneficial effect on human health, v) regulation of apoptosis and cell viability, vi) Isolation and characterization of bioactive components from functional foods, vii) Nutritional genomics, and viii) Nutritional proteomics.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
